Loading…

TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder

Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating disorder of the central nervous system (CNS) triggered by autoimmune mechanisms. Microglia are activated and play a pivotal role in response to tissue injury. Triggering receptor expressed on myeloid cells 2 (TREM2) is e...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neuroinflammation 2023-04, Vol.20 (1), p.89-89, Article 89
Main Authors: You, Yun-Fan, Chen, Man, Tang, Yue, Yu, Wen-Xiang, Pang, Xiao-Wei, Chu, Yun-Hui, Zhang, Hang, Shang, Ke, Deng, Gang, Zhou, Luo-Qi, Yang, Sheng, Wang, Wei, Xiao, Jun, Tian, Dai-Shi, Qin, Chuan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c564t-fd84918ccbb2db396f3394d2a044814e71eff796e16eeeabd5548371a3be21e53
cites cdi_FETCH-LOGICAL-c564t-fd84918ccbb2db396f3394d2a044814e71eff796e16eeeabd5548371a3be21e53
container_end_page 89
container_issue 1
container_start_page 89
container_title Journal of neuroinflammation
container_volume 20
creator You, Yun-Fan
Chen, Man
Tang, Yue
Yu, Wen-Xiang
Pang, Xiao-Wei
Chu, Yun-Hui
Zhang, Hang
Shang, Ke
Deng, Gang
Zhou, Luo-Qi
Yang, Sheng
Wang, Wei
Xiao, Jun
Tian, Dai-Shi
Qin, Chuan
description Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating disorder of the central nervous system (CNS) triggered by autoimmune mechanisms. Microglia are activated and play a pivotal role in response to tissue injury. Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed by microglia and promotes microglial activation, survival and phagocytosis. Here, we identify a critical role for TREM2 in microglial activation and function during AQP4-IgG and complement-induced demyelination. TREM2-deficient mice had more severe tissue damage and neurological impairment, as well as fewer oligodendrocytes with suppressed proliferation and maturation. The number of microglia clustering in NMOSD lesions and their proliferation were reduced in TREM2-deficient mice. Moreover, morphology analysis and expression of classic markers showed compromised activation of microglia in TREM2-deficient mice, which was accompanied by suppressed phagocytosis and degradation of myelin debris by microglia. These results overall indicate that TREM2 is a key regulator of microglial activation and exert neuroprotective effects in NMOSD demyelination.
doi_str_mv 10.1186/s12974-023-02772-3
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_640bed233aa54a44b7d224c0af3bb0b4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A744216933</galeid><doaj_id>oai_doaj_org_article_640bed233aa54a44b7d224c0af3bb0b4</doaj_id><sourcerecordid>A744216933</sourcerecordid><originalsourceid>FETCH-LOGICAL-c564t-fd84918ccbb2db396f3394d2a044814e71eff796e16eeeabd5548371a3be21e53</originalsourceid><addsrcrecordid>eNptUk1v1DAQjRCIloU_wAFF4sIlxV-JkxOqqgKVipBQOVtje5J6ldiLnVTaQ_873t1Sughblu2Zec8z41cUbyk5o7RtPibKOikqwnheUrKKPytOqRSsYqQTz5-cT4pXKa0J4axu2MvihEtCeS34aXF_8-PyGyst9s449GZbOn_rtJtTOTkTwzA6GEsws7uD2QVfgrclDEOEfMeUgdMWR-ez0w8Zu17ijqL0uMSwd80ulWEzOwNl2qCZ4zKV1qUQLcbXxYsexoRvHvZV8fPz5c3F1-r6-5eri_PrytSNmKvetqKjrTFaM6t51_Scd8IyIEK0VKCk2Peya5A2iAja1rVouaTANTKKNV8VVwdeG2CtNtFNELcqgFN7Q4iDgphTHFE1gmi0jHOAWoAQWlrGhCHQc62JFpnr04Frs-gJrUE_RxiPSI893t2qIdwpSkjTEbnL5sMDQwy_FkyzmlwyOI7gMSxJMdnVvKE8j1Xx_p_QdViiz71SrCWcCMkb8TdqgFyB833ID5sdqTqXQjDadHuus_9E5Zn_0JngswSy_QjADoCsg5Qi9o9FUqJ2ClQHBaqsQLVXoNqB3j1tzyPkj-T4b9ii2IU</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2803047364</pqid></control><display><type>article</type><title>TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder</title><source>PubMed Central Free</source><source>Publicly Available Content Database</source><creator>You, Yun-Fan ; Chen, Man ; Tang, Yue ; Yu, Wen-Xiang ; Pang, Xiao-Wei ; Chu, Yun-Hui ; Zhang, Hang ; Shang, Ke ; Deng, Gang ; Zhou, Luo-Qi ; Yang, Sheng ; Wang, Wei ; Xiao, Jun ; Tian, Dai-Shi ; Qin, Chuan</creator><creatorcontrib>You, Yun-Fan ; Chen, Man ; Tang, Yue ; Yu, Wen-Xiang ; Pang, Xiao-Wei ; Chu, Yun-Hui ; Zhang, Hang ; Shang, Ke ; Deng, Gang ; Zhou, Luo-Qi ; Yang, Sheng ; Wang, Wei ; Xiao, Jun ; Tian, Dai-Shi ; Qin, Chuan</creatorcontrib><description>Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating disorder of the central nervous system (CNS) triggered by autoimmune mechanisms. Microglia are activated and play a pivotal role in response to tissue injury. Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed by microglia and promotes microglial activation, survival and phagocytosis. Here, we identify a critical role for TREM2 in microglial activation and function during AQP4-IgG and complement-induced demyelination. TREM2-deficient mice had more severe tissue damage and neurological impairment, as well as fewer oligodendrocytes with suppressed proliferation and maturation. The number of microglia clustering in NMOSD lesions and their proliferation were reduced in TREM2-deficient mice. Moreover, morphology analysis and expression of classic markers showed compromised activation of microglia in TREM2-deficient mice, which was accompanied by suppressed phagocytosis and degradation of myelin debris by microglia. These results overall indicate that TREM2 is a key regulator of microglial activation and exert neuroprotective effects in NMOSD demyelination.</description><identifier>ISSN: 1742-2094</identifier><identifier>EISSN: 1742-2094</identifier><identifier>DOI: 10.1186/s12974-023-02772-3</identifier><identifier>PMID: 37013543</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Alcohol ; Alzheimer's disease ; Animals ; Antibodies ; Aquaporin 4 ; Brain ; Care and treatment ; Central Nervous System ; Complement activation ; Cytotoxicity ; Demyelinating diseases ; Demyelination ; Diagnosis ; Dosage and administration ; Immunoglobulin G ; Membrane Glycoproteins - genetics ; Membrane Glycoproteins - metabolism ; Mice ; Microglia ; Microglia - metabolism ; Microscopy ; Morphology ; Myelin ; Myelin Sheath - metabolism ; Myeloid cells ; Neurological complications ; Neuromyelitis ; Neuromyelitis optica ; Neuromyelitis Optica - metabolism ; Neuromyelitis optica spectrum disorder ; Neuroprotection ; Oligodendrocytes ; Phagocytosis ; Phagocytosis - genetics ; Proteins ; Receptors, Immunologic - genetics ; Receptors, Immunologic - metabolism ; TREM2</subject><ispartof>Journal of neuroinflammation, 2023-04, Vol.20 (1), p.89-89, Article 89</ispartof><rights>2023. The Author(s).</rights><rights>COPYRIGHT 2023 BioMed Central Ltd.</rights><rights>2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c564t-fd84918ccbb2db396f3394d2a044814e71eff796e16eeeabd5548371a3be21e53</citedby><cites>FETCH-LOGICAL-c564t-fd84918ccbb2db396f3394d2a044814e71eff796e16eeeabd5548371a3be21e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069075/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2803047364?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37013543$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>You, Yun-Fan</creatorcontrib><creatorcontrib>Chen, Man</creatorcontrib><creatorcontrib>Tang, Yue</creatorcontrib><creatorcontrib>Yu, Wen-Xiang</creatorcontrib><creatorcontrib>Pang, Xiao-Wei</creatorcontrib><creatorcontrib>Chu, Yun-Hui</creatorcontrib><creatorcontrib>Zhang, Hang</creatorcontrib><creatorcontrib>Shang, Ke</creatorcontrib><creatorcontrib>Deng, Gang</creatorcontrib><creatorcontrib>Zhou, Luo-Qi</creatorcontrib><creatorcontrib>Yang, Sheng</creatorcontrib><creatorcontrib>Wang, Wei</creatorcontrib><creatorcontrib>Xiao, Jun</creatorcontrib><creatorcontrib>Tian, Dai-Shi</creatorcontrib><creatorcontrib>Qin, Chuan</creatorcontrib><title>TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder</title><title>Journal of neuroinflammation</title><addtitle>J Neuroinflammation</addtitle><description>Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating disorder of the central nervous system (CNS) triggered by autoimmune mechanisms. Microglia are activated and play a pivotal role in response to tissue injury. Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed by microglia and promotes microglial activation, survival and phagocytosis. Here, we identify a critical role for TREM2 in microglial activation and function during AQP4-IgG and complement-induced demyelination. TREM2-deficient mice had more severe tissue damage and neurological impairment, as well as fewer oligodendrocytes with suppressed proliferation and maturation. The number of microglia clustering in NMOSD lesions and their proliferation were reduced in TREM2-deficient mice. Moreover, morphology analysis and expression of classic markers showed compromised activation of microglia in TREM2-deficient mice, which was accompanied by suppressed phagocytosis and degradation of myelin debris by microglia. These results overall indicate that TREM2 is a key regulator of microglial activation and exert neuroprotective effects in NMOSD demyelination.</description><subject>Alcohol</subject><subject>Alzheimer's disease</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Aquaporin 4</subject><subject>Brain</subject><subject>Care and treatment</subject><subject>Central Nervous System</subject><subject>Complement activation</subject><subject>Cytotoxicity</subject><subject>Demyelinating diseases</subject><subject>Demyelination</subject><subject>Diagnosis</subject><subject>Dosage and administration</subject><subject>Immunoglobulin G</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Membrane Glycoproteins - metabolism</subject><subject>Mice</subject><subject>Microglia</subject><subject>Microglia - metabolism</subject><subject>Microscopy</subject><subject>Morphology</subject><subject>Myelin</subject><subject>Myelin Sheath - metabolism</subject><subject>Myeloid cells</subject><subject>Neurological complications</subject><subject>Neuromyelitis</subject><subject>Neuromyelitis optica</subject><subject>Neuromyelitis Optica - metabolism</subject><subject>Neuromyelitis optica spectrum disorder</subject><subject>Neuroprotection</subject><subject>Oligodendrocytes</subject><subject>Phagocytosis</subject><subject>Phagocytosis - genetics</subject><subject>Proteins</subject><subject>Receptors, Immunologic - genetics</subject><subject>Receptors, Immunologic - metabolism</subject><subject>TREM2</subject><issn>1742-2094</issn><issn>1742-2094</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUk1v1DAQjRCIloU_wAFF4sIlxV-JkxOqqgKVipBQOVtje5J6ldiLnVTaQ_873t1Sughblu2Zec8z41cUbyk5o7RtPibKOikqwnheUrKKPytOqRSsYqQTz5-cT4pXKa0J4axu2MvihEtCeS34aXF_8-PyGyst9s449GZbOn_rtJtTOTkTwzA6GEsws7uD2QVfgrclDEOEfMeUgdMWR-ez0w8Zu17ijqL0uMSwd80ulWEzOwNl2qCZ4zKV1qUQLcbXxYsexoRvHvZV8fPz5c3F1-r6-5eri_PrytSNmKvetqKjrTFaM6t51_Scd8IyIEK0VKCk2Peya5A2iAja1rVouaTANTKKNV8VVwdeG2CtNtFNELcqgFN7Q4iDgphTHFE1gmi0jHOAWoAQWlrGhCHQc62JFpnr04Frs-gJrUE_RxiPSI893t2qIdwpSkjTEbnL5sMDQwy_FkyzmlwyOI7gMSxJMdnVvKE8j1Xx_p_QdViiz71SrCWcCMkb8TdqgFyB833ID5sdqTqXQjDadHuus_9E5Zn_0JngswSy_QjADoCsg5Qi9o9FUqJ2ClQHBaqsQLVXoNqB3j1tzyPkj-T4b9ii2IU</recordid><startdate>20230403</startdate><enddate>20230403</enddate><creator>You, Yun-Fan</creator><creator>Chen, Man</creator><creator>Tang, Yue</creator><creator>Yu, Wen-Xiang</creator><creator>Pang, Xiao-Wei</creator><creator>Chu, Yun-Hui</creator><creator>Zhang, Hang</creator><creator>Shang, Ke</creator><creator>Deng, Gang</creator><creator>Zhou, Luo-Qi</creator><creator>Yang, Sheng</creator><creator>Wang, Wei</creator><creator>Xiao, Jun</creator><creator>Tian, Dai-Shi</creator><creator>Qin, Chuan</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230403</creationdate><title>TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder</title><author>You, Yun-Fan ; Chen, Man ; Tang, Yue ; Yu, Wen-Xiang ; Pang, Xiao-Wei ; Chu, Yun-Hui ; Zhang, Hang ; Shang, Ke ; Deng, Gang ; Zhou, Luo-Qi ; Yang, Sheng ; Wang, Wei ; Xiao, Jun ; Tian, Dai-Shi ; Qin, Chuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c564t-fd84918ccbb2db396f3394d2a044814e71eff796e16eeeabd5548371a3be21e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Alcohol</topic><topic>Alzheimer's disease</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Aquaporin 4</topic><topic>Brain</topic><topic>Care and treatment</topic><topic>Central Nervous System</topic><topic>Complement activation</topic><topic>Cytotoxicity</topic><topic>Demyelinating diseases</topic><topic>Demyelination</topic><topic>Diagnosis</topic><topic>Dosage and administration</topic><topic>Immunoglobulin G</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Membrane Glycoproteins - metabolism</topic><topic>Mice</topic><topic>Microglia</topic><topic>Microglia - metabolism</topic><topic>Microscopy</topic><topic>Morphology</topic><topic>Myelin</topic><topic>Myelin Sheath - metabolism</topic><topic>Myeloid cells</topic><topic>Neurological complications</topic><topic>Neuromyelitis</topic><topic>Neuromyelitis optica</topic><topic>Neuromyelitis Optica - metabolism</topic><topic>Neuromyelitis optica spectrum disorder</topic><topic>Neuroprotection</topic><topic>Oligodendrocytes</topic><topic>Phagocytosis</topic><topic>Phagocytosis - genetics</topic><topic>Proteins</topic><topic>Receptors, Immunologic - genetics</topic><topic>Receptors, Immunologic - metabolism</topic><topic>TREM2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>You, Yun-Fan</creatorcontrib><creatorcontrib>Chen, Man</creatorcontrib><creatorcontrib>Tang, Yue</creatorcontrib><creatorcontrib>Yu, Wen-Xiang</creatorcontrib><creatorcontrib>Pang, Xiao-Wei</creatorcontrib><creatorcontrib>Chu, Yun-Hui</creatorcontrib><creatorcontrib>Zhang, Hang</creatorcontrib><creatorcontrib>Shang, Ke</creatorcontrib><creatorcontrib>Deng, Gang</creatorcontrib><creatorcontrib>Zhou, Luo-Qi</creatorcontrib><creatorcontrib>Yang, Sheng</creatorcontrib><creatorcontrib>Wang, Wei</creatorcontrib><creatorcontrib>Xiao, Jun</creatorcontrib><creatorcontrib>Tian, Dai-Shi</creatorcontrib><creatorcontrib>Qin, Chuan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of neuroinflammation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>You, Yun-Fan</au><au>Chen, Man</au><au>Tang, Yue</au><au>Yu, Wen-Xiang</au><au>Pang, Xiao-Wei</au><au>Chu, Yun-Hui</au><au>Zhang, Hang</au><au>Shang, Ke</au><au>Deng, Gang</au><au>Zhou, Luo-Qi</au><au>Yang, Sheng</au><au>Wang, Wei</au><au>Xiao, Jun</au><au>Tian, Dai-Shi</au><au>Qin, Chuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder</atitle><jtitle>Journal of neuroinflammation</jtitle><addtitle>J Neuroinflammation</addtitle><date>2023-04-03</date><risdate>2023</risdate><volume>20</volume><issue>1</issue><spage>89</spage><epage>89</epage><pages>89-89</pages><artnum>89</artnum><issn>1742-2094</issn><eissn>1742-2094</eissn><abstract>Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating disorder of the central nervous system (CNS) triggered by autoimmune mechanisms. Microglia are activated and play a pivotal role in response to tissue injury. Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed by microglia and promotes microglial activation, survival and phagocytosis. Here, we identify a critical role for TREM2 in microglial activation and function during AQP4-IgG and complement-induced demyelination. TREM2-deficient mice had more severe tissue damage and neurological impairment, as well as fewer oligodendrocytes with suppressed proliferation and maturation. The number of microglia clustering in NMOSD lesions and their proliferation were reduced in TREM2-deficient mice. Moreover, morphology analysis and expression of classic markers showed compromised activation of microglia in TREM2-deficient mice, which was accompanied by suppressed phagocytosis and degradation of myelin debris by microglia. These results overall indicate that TREM2 is a key regulator of microglial activation and exert neuroprotective effects in NMOSD demyelination.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>37013543</pmid><doi>10.1186/s12974-023-02772-3</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1742-2094
ispartof Journal of neuroinflammation, 2023-04, Vol.20 (1), p.89-89, Article 89
issn 1742-2094
1742-2094
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_640bed233aa54a44b7d224c0af3bb0b4
source PubMed Central Free; Publicly Available Content Database
subjects Alcohol
Alzheimer's disease
Animals
Antibodies
Aquaporin 4
Brain
Care and treatment
Central Nervous System
Complement activation
Cytotoxicity
Demyelinating diseases
Demyelination
Diagnosis
Dosage and administration
Immunoglobulin G
Membrane Glycoproteins - genetics
Membrane Glycoproteins - metabolism
Mice
Microglia
Microglia - metabolism
Microscopy
Morphology
Myelin
Myelin Sheath - metabolism
Myeloid cells
Neurological complications
Neuromyelitis
Neuromyelitis optica
Neuromyelitis Optica - metabolism
Neuromyelitis optica spectrum disorder
Neuroprotection
Oligodendrocytes
Phagocytosis
Phagocytosis - genetics
Proteins
Receptors, Immunologic - genetics
Receptors, Immunologic - metabolism
TREM2
title TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T20%3A06%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TREM2%20deficiency%20inhibits%20microglial%20activation%20and%20aggravates%20demyelinating%20injury%20in%20neuromyelitis%20optica%20spectrum%20disorder&rft.jtitle=Journal%20of%20neuroinflammation&rft.au=You,%20Yun-Fan&rft.date=2023-04-03&rft.volume=20&rft.issue=1&rft.spage=89&rft.epage=89&rft.pages=89-89&rft.artnum=89&rft.issn=1742-2094&rft.eissn=1742-2094&rft_id=info:doi/10.1186/s12974-023-02772-3&rft_dat=%3Cgale_doaj_%3EA744216933%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c564t-fd84918ccbb2db396f3394d2a044814e71eff796e16eeeabd5548371a3be21e53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2803047364&rft_id=info:pmid/37013543&rft_galeid=A744216933&rfr_iscdi=true